Tattooing and autoinflammatory diseases: a study among 197 French patients from the JIR cohort
J Eur Acad Dermatol Venereol
.
2022 May;36(5):e363-e365.
doi: 10.1111/jdv.17886.
Epub 2022 Jan 5.
Authors
N Kluger
1
2
,
R Bourguiba
3
4
,
M Delplanque
3
4
,
V Hentgen
4
5
,
I Kone-Paut
4
6
,
L Savey
3
4
,
G Grateau
3
4
,
S Georgin-Lavialle
3
4
Affiliations
1
"Tattoo" Consultation, Department of Dermatology, Assistance Publique-Hôpitaux de Paris, Bichat-Claude Bernard Hospital, Paris, France.
2
Department of Dermatology, Allergology and Venereology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
3
Internal Medicine Department, AP-HP, Tenon Hospital, Sorbonne University, Paris, France.
4
Centre de Référence des Maladies Auto-inflammatoires et des Amyloses Inflammatoire (CEREMAIA), Paris, France.
5
Department of General Pediatrics, Andre Mignot Hospital, Versailles, CEREMAIA, Paris, France.
6
Department of Pediatric Rheumatology and CEREMAIA, Bicêtre Hospital, APHP, University of Paris Saclay, Paris, France.
PMID:
34923687
DOI:
10.1111/jdv.17886
No abstract available
Publication types
Letter
MeSH terms
Cohort Studies
Hereditary Autoinflammatory Diseases*
Humans
Tattooing* / adverse effects